CLINICAL_TRIALS
trial_result
· 2016-09-20
Clinical Trial Update: Efficacy of TAK-085 in Participants With Hypertriglyceridemia [Phase 3]
Summary
A Phase 3 trial evaluated the efficacy of TAK-085 in hypertriglyceridemia, and the efficacy results have been posted for a completed study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2016-09-20